BlueLinx (BXC) Financials

$46.17 -2.49 (-5.12%)

Closing price 03:59 PM Eastern

Extended Trading

$49.66 +3.48 (+7.55%)

As of 04:34 PM Eastern

Annual Income Statements for BlueLinx

This table shows BlueLinx's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/30/2023	12/28/2024
Net Income / (Loss) Attributable to Common Shareholders	296	49	53
Consolidated Net Income / (Loss)	296	49	53
Net Income / (Loss) Continuing Operations	296	49	53
Total Pre-Tax Income	395	82	71
Total Operating Income	439	138	88
Total Gross Profit	833	527	489
Total Revenue	4,450	3,136	2,953
Operating Revenue	4,450	3,136	2,953
Total Cost of Revenue	3,617	2,609	2,463
Operating Cost of Revenue	3,617	2,609	2,463
Total Operating Expenses	394	389	402
Selling, General & Admin Expense	370	360	367
Depreciation Expense	28	32	38
Other Operating Expenses / (Income)	-	-3.93	-3.93
Other Special Charges / (Income)	-0.14	0.00	-0.27
Total Other Income / (Expense), net	-44	-57	-17
Interest & Investment Income	-42	-24	-19
Other Income / (Expense), net	-2.05	-33	2.48
Income Tax Expense	99	33	18
Basic Earnings per Share	$31.75	$5.40	$6.22
Weighted Average Basic Shares Outstanding	9.06M	8.65M	8.29M
Diluted Earnings per Share	$31.51	$5.39	$6.19
Weighted Average Diluted Shares Outstanding	9.06M	8.65M	8.29M
Weighted Average Basic & Diluted Shares Outstanding	9.06M	8.65M	8.29M

This table shows BlueLinx's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	10/1/2022	12/31/2022	4/1/2023	7/1/2023	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024	3/29/2025
Net Income / (Loss) Attributable to Common Shareholders	60	32	18	24	24	-18	17	14	16	5.27	2.81
Consolidated Net Income / (Loss)	60	32	18	24	24	-18	17	14	16	5.27	2.81
Net Income / (Loss) Continuing Operations	60	32	18	24	24	-18	17	14	16	5.27	2.81
Total Pre-Tax Income	81	41	24	32	33	-8.02	23	19	22	6.97	4.14
Total Operating Income	91	51	33	39	40	27	28	24	24	12	11
Total Gross Profit	189	151	134	136	139	118	128	122	126	113	111
Total Revenue	1,061	848	798	816	810	713	726	768	747	711	709
Operating Revenue	1,061	848	798	816	810	713	726	768	747	711	709
Total Cost of Revenue	871	697	664	680	671	594	599	646	622	597	598
Operating Cost of Revenue	871	697	664	680	671	594	599	646	622	597	598
Total Operating Expenses	99	100	101	97	100	91	100	99	102	101	100
Selling, General & Admin Expense	93	93	94	90	92	84	92	89	93	93	94
Depreciation Expense	6.69	7.66	7.72	7.95	8.09	8.29	9.43	10	9.53	9.41	9.55
Other Operating Expenses / (Income)	-0.98	-	-0.98	-0.98	-0.98	-0.98	-0.98	-0.98	-0.98	-0.98	-3.24
Total Other Income / (Expense), net	-10	-12	-8.28	-6.91	-6.17	-35	-4.62	-4.80	-2.39	-5.07	-6.58
Interest & Investment Income	-	-	-	-6.31	-5.58	-	-	-4.80	-4.62	-	-6.58
Income Tax Expense	21	8.74	6.42	7.72	9.10	10	5.55	4.71	5.62	1.69	1.34
Basic Earnings per Share	$6.44	$3.95	$1.96	$2.70	$2.72	($1.98)	$2.02	$1.65	$1.88	$0.67	$0.33
Weighted Average Basic Shares Outstanding	9.04M	9.06M	9.09M	9.00M	8.77M	8.65M	8.66M	8.53M	8.38M	8.29M	8.02M
Diluted Earnings per Share	$6.38	$4.46	$1.94	$2.70	$2.71	($1.96)	$2.00	$1.65	$1.87	$0.67	$0.33
Weighted Average Diluted Shares Outstanding	9.04M	9.06M	9.09M	9.00M	8.77M	8.65M	8.66M	8.53M	8.38M	8.29M	8.02M
Weighted Average Basic & Diluted Shares Outstanding	9.04M	9.06M	9.09M	9.00M	8.77M	8.65M	8.66M	8.53M	8.38M	8.29M	8.02M

This table details how cash moves in and out of BlueLinx's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/30/2023	12/28/2024
Net Change in Cash & Equivalents	214	223	-16
Net Cash From Operating Activities	400	306	85
Net Cash From Continuing Operating Activities	400	306	85
Net Income / (Loss) Continuing Operations	296	49	53
Consolidated Net Income / (Loss)	296	49	53
Depreciation Expense	28	32	38
Amortization Expense	-2.78	-2.62	-2.62
Non-Cash Adjustments To Reconcile Net Income	9.47	42	7.48
Changes in Operating Assets and Liabilities, net	70	187	-11
Net Cash From Investing Activities	-99	-27	-39
Net Cash From Continuing Investing Activities	-99	-27	-39
Purchase of Property, Plant & Equipment	-36	-28	-40
Acquisitions	-64	0.30	0.00
Sale of Property, Plant & Equipment	0.96	0.36	0.90
Net Cash From Financing Activities	-88	-57	-62
Net Cash From Continuing Financing Activities	-88	-57	-62
Repurchase of Common Equity	-66	-42	-45
Other Financing Activities, net	-21	-14	-17
Cash Interest Paid	44	43	45
Cash Income Taxes Paid	111	19	30

This table details how cash moves in and out of BlueLinx's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	10/1/2022	12/31/2022	4/1/2023	7/1/2023	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024	3/29/2025
Net Change in Cash & Equivalents	124	70	77	42	51	52	-40	10	35	-21	-57
Net Cash From Operating Activities	143	154	89	64	78	76	-31	36	62	19	-34
Net Cash From Continuing Operating Activities	143	154	89	64	78	76	-31	36	62	19	-34
Net Income / (Loss) Continuing Operations	60	32	18	24	24	-18	17	14	16	5.27	2.81
Consolidated Net Income / (Loss)	60	32	18	24	24	-18	17	14	16	5.27	2.81
Depreciation Expense	6.69	7.66	7.72	7.95	8.09	8.29	9.43	10	9.53	9.41	9.55
Amortization Expense	-0.65	-0.65	-0.66	-0.65	-0.65	-0.65	-0.65	-0.65	-0.65	-0.65	-0.65
Non-Cash Adjustments To Reconcile Net Income	2.09	3.59	4.57	1.93	2.98	32	2.35	1.41	0.96	2.76	0.08
Changes in Operating Assets and Liabilities, net	75	112	60	30	43	54	-60	11	36	1.96	-46
Net Cash From Investing Activities	-12	-80	-8.97	-4.94	-4.84	-8.12	-5.32	-6.31	-7.36	-20	-3.39
Net Cash From Continuing Investing Activities	-12	-80	-8.97	-4.94	-4.84	-8.12	-5.32	-6.31	-7.36	-20	-3.39
Purchase of Property, Plant & Equipment	-12	-17	-9.01	-5.03	-4.90	-8.58	-5.45	-6.45	-7.93	-20	-5.93
Other Investing Activities, net	-	-	-	-	-	-	-	-	-	-	2.54
Net Cash From Financing Activities	-6.11	-4.42	-2.70	-17	-21	-15	-3.98	-19	-20	-19	-19
Net Cash From Continuing Financing Activities	-6.11	-4.42	-2.70	-17	-21	-15	-3.98	-19	-20	-19	-19
Repurchase of Common Equity	-	-	-	-	-18	-13	-	-	-15	-15	-15
Other Financing Activities, net	-6.11	-4.42	-2.70	-5.52	-3.59	-2.67	-3.98	-4.88	-4.06	-3.87	-4.30
Cash Interest Paid	2.12	19	6.19	15	6.48	15	6.80	15	6.88	16	7.16
Cash Income Taxes Paid	29	21	0.00	11	6.86	1.56	1.34	21	2.13	6.18	-1.08

This table presents BlueLinx's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/30/2023	12/28/2024
Total Assets	1,490	1,538	1,578
Total Current Assets	1,077	1,120	1,134
Cash & Equivalents	299	522	506
Accounts Receivable	252	228	226
Inventories, net	484	344	356
Other Current Assets	42	27	47
Plant, Property, & Equipment, net	206	226	250
Total Noncurrent Assets	208	191	194
Goodwill	55	55	55
Intangible Assets	35	31	27
Noncurrent Deferred & Refundable Income Taxes	56	53	51
Other Noncurrent Operating Assets	61	52	61
Total Liabilities & Shareholders' Equity	1,490	1,538	1,578
Total Liabilities	900	903	931
Total Current Liabilities	211	219	234
Accounts Payable	152	158	170
Current Deferred Revenue	3.94	3.94	3.94
Current Employee Benefit Liabilities	23	14	17
Other Current Liabilities	33	42	43
Total Noncurrent Liabilities	689	685	698
Long-Term Debt	292	294	295
Other Noncurrent Operating Liabilities	397	391	402
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	590	634	646
Total Preferred & Common Equity	590	634	646
Preferred Stock	0.00	0.00	0.00
Total Common Equity	590	634	646
Common Stock	201	165	124
Retained Earnings	421	469	522

This table presents BlueLinx's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	10/1/2022	4/1/2023	7/1/2023	9/30/2023	3/30/2024	6/29/2024	9/28/2024	3/29/2025
Total Assets	1,534	1,526	1,550	1,585	1,592	1,586	1,611	1,633
Total Current Assets	1,158	1,114	1,137	1,171	1,173	1,159	1,181	1,166
Cash & Equivalents	229	376	418	470	481	491	526	449
Accounts Receivable	361	299	294	298	288	274	278	276
Inventories, net	536	409	379	364	371	358	341	400
Other Current Assets	32	29	45	40	32	36	37	42
Plant, Property, & Equipment, net	189	208	210	216	231	232	236	275
Plant, Property & Equipment, gross	340	366	374	382	407	414	424	462
Accumulated Depreciation	151	158	163	166	176	182	188	187
Total Noncurrent Assets	187	204	203	199	188	195	194	192
Goodwill	48	55	55	55	55	55	55	55
Intangible Assets	11	34	33	32	30	29	28	26
Noncurrent Deferred & Refundable Income Taxes	61	56	56	55	54	54	51	51
Other Noncurrent Operating Assets	66	59	59	57	49	57	59	60
Total Liabilities & Shareholders' Equity	1,534	1,526	1,550	1,585	1,592	1,586	1,611	1,633
Total Liabilities	976	915	928	954	938	934	955	997
Total Current Liabilities	273	228	245	268	249	237	258	281
Accounts Payable	208	177	190	202	172	179	186	213
Current Deferred Revenue	-	3.94	3.94	3.94	3.94	3.94	3.94	3.94
Current Employee Benefit Liabilities	18	15	16	21	14	12	18	14
Other Current Liabilities	40	32	34	41	60	42	49	50
Total Noncurrent Liabilities	703	687	683	686	689	696	698	717
Long-Term Debt	292	293	293	293	294	294	295	295
Other Noncurrent Operating Liabilities	330	394	390	393	395	402	403	421
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	558	611	623	632	653	652	656	636
Total Preferred & Common Equity	558	611	623	632	653	652	656	636
Preferred Stock	-	-	-	-	0.00	0.00	0.00	0.00
Total Common Equity	558	611	623	632	653	652	656	636
Common Stock	198	204	191	175	167	151	139	111
Retained Earnings	389	438	463	487	487	501	517	525

This table displays calculated financial ratios and metrics derived from BlueLinx's official financial filings.

Metric	2022	2023	2024
Period end date	12/31/2022	12/30/2023	12/28/2024
Growth Metrics	-	-	-
Revenue Growth	4.05%	-29.52%	-5.86%
EBITDA Growth	-0.69%	-70.76%	-6.77%
EBIT Growth	-0.53%	-75.83%	-14.75%
NOPAT Growth	0.02%	-75.09%	-19.81%
Net Income Growth	0.01%	-83.61%	9.44%
EPS Growth	5.07%	-82.89%	14.84%
Operating Cash Flow Growth	176.02%	-23.49%	-72.19%
Free Cash Flow Firm Growth	122.79%	-17.75%	-86.04%
Invested Capital Growth	2.49%	-30.37%	7.28%
Revenue Q/Q Growth	-2.74%	-4.13%	-0.06%
EBITDA Q/Q Growth	-11.47%	-29.37%	15.88%
EBIT Q/Q Growth	-12.29%	-34.96%	21.83%
NOPAT Q/Q Growth	-11.43%	-33.09%	20.05%
Net Income Q/Q Growth	-12.32%	-50.80%	78.72%
EPS Q/Q Growth	-8.43%	-54.36%	73.88%
Operating Cash Flow Q/Q Growth	51.51%	-20.44%	-40.01%
Free Cash Flow Firm Q/Q Growth	22.70%	-27.83%	-57.85%
Invested Capital Q/Q Growth	-15.65%	-10.73%	2.79%
Profitability Metrics	-	-	-
Gross Margin	18.72%	16.80%	16.57%
EBITDA Margin	10.38%	4.31%	4.26%
Operating Margin	9.87%	4.41%	2.97%
EBIT Margin	9.82%	3.37%	3.05%
Profit (Net Income) Margin	6.66%	1.55%	1.80%
Tax Burden Percent	75.03%	59.27%	75.14%
Interest Burden Percent	90.33%	77.52%	78.50%
Effective Tax Rate	24.97%	40.73%	24.86%
Return on Invested Capital (ROIC)	57.15%	16.58%	15.63%
ROIC Less NNEP Spread (ROIC-NNEP)	23.82%	45.17%	21.41%
Return on Net Nonoperating Assets (RNNOA)	4.99%	-8.65%	-7.33%
Return on Equity (ROE)	62.14%	7.93%	8.29%
Cash Return on Invested Capital (CROIC)	54.69%	52.39%	8.60%
Operating Return on Assets (OROA)	31.13%	6.98%	5.78%
Return on Assets (ROA)	21.10%	3.21%	3.41%
Return on Common Equity (ROCE)	62.14%	7.93%	8.29%
Return on Equity Simple (ROE_SIMPLE)	50.20%	7.65%	8.22%
Net Operating Profit after Tax (NOPAT)	329	82	66
NOPAT Margin	7.40%	2.62%	2.23%
Net Nonoperating Expense Percent (NNEP)	33.33%	-28.59%	-5.79%
Return On Investment Capital (ROIC_SIMPLE)	37.33%	8.84%	6.99%
Cost of Revenue to Revenue	81.28%	83.20%	83.43%
SG&A Expenses to Revenue	8.32%	11.49%	12.44%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	8.85%	12.39%	13.60%
Earnings before Interest and Taxes (EBIT)	437	106	90
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	462	135	126
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	1.09	1.57	1.34
Price to Tangible Book Value (P/TBV)	1.29	1.81	1.54
Price to Revenue (P/Rev)	0.14	0.32	0.29
Price to Earnings (P/E)	2.17	20.47	16.37
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	46.10%	4.89%	6.11%
Enterprise Value to Invested Capital (EV/IC)	1.09	1.88	1.51
Enterprise Value to Revenue (EV/Rev)	0.14	0.24	0.22
Enterprise Value to EBITDA (EV/EBITDA)	1.38	5.67	5.23
Enterprise Value to EBIT (EV/EBIT)	1.46	7.25	7.31
Enterprise Value to NOPAT (EV/NOPAT)	1.93	9.33	10.01
Enterprise Value to Operating Cash Flow (EV/OCF)	1.59	2.50	7.73
Enterprise Value to Free Cash Flow (EV/FCFF)	2.02	2.95	18.19
Leverage & Solvency	-	-	-
Debt to Equity	0.50	0.46	0.46
Long-Term Debt to Equity	0.50	0.46	0.46
Financial Leverage	0.21	-0.19	-0.34
Leverage Ratio	2.95	2.47	2.43
Compound Leverage Factor	2.66	1.92	1.91
Debt to Total Capital	33.14%	31.65%	31.34%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	33.14%	31.65%	31.34%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	66.86%	68.35%	68.66%
Debt to EBITDA	0.63	2.17	2.34
Net Debt to EBITDA	-0.01	-1.69	-1.67
Long-Term Debt to EBITDA	0.63	2.17	2.34
Debt to NOPAT	0.89	3.58	4.48
Net Debt to NOPAT	-0.02	-2.78	-3.20
Long-Term Debt to NOPAT	0.89	3.58	4.48
Altman Z-Score	5.48	4.06	3.77
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	5.11	5.13	4.85
Quick Ratio	2.61	3.43	3.13
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	315	259	36
Operating Cash Flow to CapEx	1,146.26%	1,127.58%	217.24%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	3.17	2.07	1.90
Accounts Receivable Turnover	15.06	13.07	13.00
Inventory Turnover	7.44	6.30	7.04
Fixed Asset Turnover	0.00	14.53	12.42
Accounts Payable Turnover	21.82	16.86	15.01
Days Sales Outstanding (DSO)	24.24	27.93	28.08
Days Inventory Outstanding (DIO)	49.08	57.91	51.83
Days Payable Outstanding (DPO)	16.73	21.65	24.31
Cash Conversion Cycle (CCC)	56.59	64.18	55.59
Capital & Investment Metrics	-	-	-
Invested Capital	584	406	436
Invested Capital Turnover	7.72	6.34	7.01
Increase / (Decrease) in Invested Capital	14	-177	30
Enterprise Value (EV)	636	765	659
Market Capitalization	643	993	869
Book Value per Share	$65.30	$72.35	$77.13
Tangible Book Value per Share	$55.30	$62.52	$67.32
Total Capital	882	928	942
Total Debt	292	294	295
Total Long-Term Debt	292	294	295
Net Debt	-6.52	-228	-211
Capital Expenditures (CapEx)	35	27	39
Debt-free, Cash-free Net Working Capital (DFCFNWC)	567	380	395
Debt-free Net Working Capital (DFNWC)	866	902	900
Net Working Capital (NWC)	866	902	900
Net Nonoperating Expense (NNE)	33	34	13
Net Nonoperating Obligations (NNO)	-6.52	-228	-211
Total Depreciation and Amortization (D&A)	25	29	36
Debt-free, Cash-free Net Working Capital to Revenue	12.75%	12.12%	13.37%
Debt-free Net Working Capital to Revenue	19.47%	28.75%	30.49%
Net Working Capital to Revenue	19.47%	28.75%	30.49%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$31.75	$5.40	$6.22
Adjusted Weighted Average Basic Shares Outstanding	9.06M	8.65M	8.29M
Adjusted Diluted Earnings per Share	$31.51	$5.39	$6.19
Adjusted Weighted Average Diluted Shares Outstanding	9.06M	8.65M	8.29M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	9.06M	8.65M	8.29M
Normalized Net Operating Profit after Tax (NOPAT)	329	82	66
Normalized NOPAT Margin	7.40%	2.62%	2.22%
Pre Tax Income Margin	8.87%	2.61%	2.39%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	22.43%	86.81%	85.28%

This table displays calculated financial ratios and metrics derived from BlueLinx's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	10/1/2022	12/31/2022	4/1/2023	7/1/2023	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024	3/29/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	9.26%	-12.87%	-38.73%	-34.16%	-23.64%	-15.95%	-8.98%	-5.83%	-7.74%	-0.27%	-2.34%
EBITDA Growth	24.24%	-49.83%	-80.43%	-58.25%	-52.13%	-93.49%	-6.51%	-27.26%	-24.45%	456.07%	-46.15%
EBIT Growth	26.96%	-53.63%	-83.47%	-62.95%	-57.12%	-107.53%	-13.32%	-38.06%	-32.80%	419.09%	-61.24%
NOPAT Growth	26.65%	-51.29%	-83.24%	-62.87%	-56.87%	-52.63%	-12.12%	-39.59%	-38.40%	-52.15%	-65.44%
Net Income Growth	26.08%	-56.55%	-86.65%	-65.67%	-59.03%	-156.66%	-1.80%	-41.40%	-34.31%	129.09%	-83.96%
EPS Growth	34.60%	-39.40%	-85.29%	-63.90%	-57.52%	-143.95%	3.09%	-38.89%	-31.00%	134.18%	-83.50%
Operating Cash Flow Growth	36.78%	749.27%	3,876.98%	-36.60%	-45.58%	-51.02%	-135.00%	-44.19%	-20.41%	-75.19%	-8.91%
Free Cash Flow Firm Growth	54.65%	124.65%	1,906.97%	665.52%	652.09%	655.55%	-60.04%	-79.34%	-81.59%	-110.44%	-111.23%
Invested Capital Growth	19.95%	2.49%	-25.66%	-34.44%	-34.21%	-30.37%	-11.62%	-8.48%	-6.83%	7.28%	3.54%
Revenue Q/Q Growth	-14.41%	-20.08%	-5.88%	2.26%	-0.73%	-12.03%	1.92%	5.80%	-2.74%	-4.90%	-0.20%
EBITDA Q/Q Growth	-11.45%	-40.12%	-32.96%	17.47%	1.53%	-91.86%	863.44%	-8.60%	5.45%	-40.11%	-6.70%
EBIT Q/Q Growth	-12.34%	-43.85%	-37.59%	20.61%	1.46%	-109.86%	818.65%	-13.81%	10.08%	-53.20%	-12.71%
NOPAT Q/Q Growth	-16.35%	-40.00%	-40.50%	24.34%	-2.82%	-34.10%	10.37%	-14.53%	-0.90%	-48.81%	-20.28%
Net Income Q/Q Growth	-16.50%	-46.25%	-44.31%	37.36%	-0.34%	-174.33%	196.51%	-18.04%	11.72%	-67.08%	-46.79%
EPS Q/Q Growth	-14.71%	-30.09%	-56.50%	39.18%	0.37%	-172.32%	202.04%	-17.50%	13.33%	-64.17%	-50.75%
Operating Cash Flow Q/Q Growth	40.92%	8.17%	-42.33%	-27.89%	20.97%	-2.64%	-141.21%	214.99%	72.52%	-69.65%	-280.90%
Free Cash Flow Firm Q/Q Growth	6.54%	154.01%	692.69%	41.34%	-8.76%	-26.09%	-58.07%	-26.92%	-18.70%	-141.91%	54.89%
Invested Capital Q/Q Growth	-8.84%	-15.65%	-9.64%	-5.64%	-8.52%	-10.73%	14.69%	-2.28%	-6.87%	2.79%	10.69%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	17.85%	17.83%	16.74%	16.64%	17.19%	16.62%	17.58%	15.94%	16.82%	15.95%	15.67%
EBITDA Margin	9.16%	6.86%	4.89%	5.61%	5.74%	0.53%	5.02%	4.34%	4.70%	2.96%	2.77%
Operating Margin	8.55%	6.03%	4.08%	4.79%	4.90%	3.82%	3.81%	3.10%	3.22%	1.69%	1.51%
EBIT Margin	8.59%	6.03%	4.00%	4.72%	4.82%	-0.54%	3.81%	3.10%	3.51%	1.73%	1.51%
Profit (Net Income) Margin	5.61%	3.77%	2.23%	3.00%	3.01%	-2.54%	2.41%	1.87%	2.14%	0.74%	0.40%
Tax Burden Percent	73.79%	78.54%	73.50%	76.01%	72.81%	225.96%	75.91%	75.27%	74.04%	75.69%	67.69%
Interest Burden Percent	88.53%	79.63%	75.92%	83.61%	85.72%	208.34%	83.29%	79.87%	82.40%	56.70%	38.64%
Effective Tax Rate	26.21%	21.46%	26.50%	23.99%	27.19%	0.00%	24.09%	24.73%	25.96%	24.31%	32.31%
Return on Invested Capital (ROIC)	45.53%	36.58%	19.12%	20.42%	20.34%	16.93%	17.85%	14.79%	16.00%	8.98%	6.34%
ROIC Less NNEP Spread (ROIC-NNEP)	42.06%	28.38%	10.00%	12.58%	41.59%	48.61%	20.44%	17.04%	16.87%	10.73%	8.95%
Return on Net Nonoperating Assets (RNNOA)	21.46%	5.94%	1.21%	1.50%	-1.48%	-9.31%	-4.38%	-4.31%	-5.35%	-3.68%	-2.37%
Return on Equity (ROE)	66.99%	42.52%	20.33%	21.92%	18.86%	7.61%	13.47%	10.49%	10.65%	5.31%	3.97%
Cash Return on Invested Capital (CROIC)	40.51%	54.69%	63.57%	67.17%	62.65%	52.39%	28.41%	22.86%	19.54%	8.60%	7.57%
Operating Return on Assets (OROA)	28.72%	19.13%	10.32%	10.86%	10.12%	-1.12%	7.49%	5.97%	6.49%	3.28%	2.75%
Return on Assets (ROA)	18.76%	11.96%	5.76%	6.90%	6.31%	-5.27%	4.74%	3.59%	3.96%	1.41%	0.72%
Return on Common Equity (ROCE)	66.99%	42.52%	20.33%	21.92%	18.86%	7.61%	13.47%	10.49%	10.65%	5.31%	3.97%
Return on Equity Simple (ROE_SIMPLE)	60.57%	0.00%	29.57%	21.48%	15.62%	0.00%	7.38%	5.84%	4.53%	0.00%	6.04%
Net Operating Profit after Tax (NOPAT)	67	40	24	30	29	19	21	18	18	9.11	7.26
NOPAT Margin	6.31%	4.74%	3.00%	3.64%	3.56%	2.67%	2.89%	2.34%	2.38%	1.28%	1.02%
Net Nonoperating Expense Percent (NNEP)	3.47%	8.20%	9.11%	7.84%	-21.25%	-31.68%	-2.59%	-2.24%	-0.87%	-1.75%	-2.61%
Return On Investment Capital (ROIC_SIMPLE)	-	4.55%	-	-	-	2.05%	-	-	-	0.97%	0.78%
Cost of Revenue to Revenue	82.15%	82.17%	83.26%	83.36%	82.81%	83.38%	82.42%	84.06%	83.18%	84.05%	84.33%
SG&A Expenses to Revenue	8.76%	11.01%	11.82%	11.00%	11.42%	11.78%	12.61%	11.64%	12.46%	13.11%	13.27%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	9.30%	11.80%	12.66%	11.85%	12.30%	12.81%	13.77%	12.83%	13.60%	14.26%	14.16%
Earnings before Interest and Taxes (EBIT)	91	51	32	38	39	-3.85	28	24	26	12	11
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	97	58	39	46	46	3.78	36	33	35	21	20
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.03	1.09	1.01	1.37	1.17	1.57	1.75	1.24	1.36	1.34	1.00
Price to Tangible Book Value (P/TBV)	1.16	1.29	1.18	1.59	1.36	1.81	2.01	1.42	1.56	1.54	1.15
Price to Revenue (P/Rev)	0.13	0.14	0.16	0.24	0.23	0.32	0.37	0.27	0.30	0.29	0.22
Price to Earnings (P/E)	1.71	2.17	3.41	6.37	7.49	20.47	23.68	21.17	29.99	16.37	16.54
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	58.60%	46.10%	29.33%	15.69%	13.35%	4.89%	4.22%	4.72%	3.33%	6.11%	6.05%
Enterprise Value to Invested Capital (EV/IC)	1.03	1.09	1.01	1.46	1.24	1.88	2.05	1.34	1.56	1.51	1.00
Enterprise Value to Revenue (EV/Rev)	0.16	0.14	0.13	0.21	0.17	0.24	0.31	0.20	0.22	0.22	0.16
Enterprise Value to EBITDA (EV/EBITDA)	1.36	1.38	1.75	3.02	2.94	5.67	7.20	5.08	6.07	5.23	4.52
Enterprise Value to EBIT (EV/EBIT)	1.43	1.46	1.91	3.41	3.46	7.25	9.42	7.03	8.93	7.31	6.82
Enterprise Value to NOPAT (EV/NOPAT)	1.91	1.93	2.52	4.53	4.59	9.33	11.96	9.13	12.04	10.01	9.19
Enterprise Value to Operating Cash Flow (EV/OCF)	2.69	1.59	1.09	1.62	1.46	2.50	5.13	3.86	4.65	7.73	5.85
Enterprise Value to Free Cash Flow (EV/FCFF)	2.77	2.02	1.35	1.72	1.57	2.95	6.76	5.59	7.68	18.19	13.42
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.65	0.50	0.48	0.47	0.46	0.46	0.45	0.45	0.45	0.46	0.46
Long-Term Debt to Equity	0.65	0.50	0.48	0.47	0.46	0.46	0.45	0.45	0.45	0.46	0.46
Financial Leverage	0.51	0.21	0.12	0.12	-0.04	-0.19	-0.21	-0.25	-0.32	-0.34	-0.26
Leverage Ratio	3.26	2.95	2.77	2.73	2.62	2.47	2.47	2.46	2.48	2.43	2.50
Compound Leverage Factor	2.88	2.35	2.11	2.28	2.25	5.15	2.05	1.96	2.05	1.38	0.97
Debt to Total Capital	39.46%	33.14%	32.40%	32.00%	31.72%	31.65%	31.04%	31.10%	31.01%	31.34%	31.71%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	39.46%	33.14%	32.40%	32.00%	31.72%	31.65%	31.04%	31.10%	31.01%	31.34%	31.71%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	60.54%	66.86%	67.60%	68.00%	68.28%	68.35%	68.96%	68.90%	68.99%	68.66%	68.29%
Debt to EBITDA	0.70	0.63	0.96	1.22	1.53	2.17	2.22	2.45	2.71	2.34	2.77
Net Debt to EBITDA	0.26	-0.01	-0.27	-0.52	-0.92	-1.69	-1.41	-1.64	-2.13	-1.67	-1.44
Long-Term Debt to EBITDA	0.70	0.63	0.96	1.22	1.53	2.17	2.22	2.45	2.71	2.34	2.77
Debt to NOPAT	0.98	0.89	1.39	1.82	2.39	3.58	3.68	4.41	5.38	4.48	5.64
Net Debt to NOPAT	0.36	-0.02	-0.40	-0.78	-1.44	-2.78	-2.35	-2.95	-4.22	-3.20	-2.93
Long-Term Debt to NOPAT	0.98	0.89	1.39	1.82	2.39	3.58	3.68	4.41	5.38	4.48	5.64
Altman Z-Score	4.58	4.62	4.16	4.01	3.72	3.82	3.84	3.61	3.58	3.61	3.30
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.24	5.11	4.88	4.65	4.37	5.13	4.71	4.88	4.58	4.85	4.16
Quick Ratio	2.16	2.61	2.96	2.91	2.86	3.43	3.09	3.22	3.12	3.13	2.58
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-48	26	206	291	266	196	82	60	49	-20	-9.24
Operating Cash Flow to CapEx	1,180.51%	935.43%	991.70%	1,298.64%	1,604.76%	897.83%	-585.24%	567.67%	838.76%	92.70%	-571.61%
Free Cash Flow to Firm to Interest Expense	-4.60	0.00	26.79	0.00	0.00	0.00	17.80	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	13.65	0.00	11.57	0.00	0.00	0.00	-6.73	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	12.50	0.00	10.41	0.00	0.00	0.00	-7.88	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	3.34	3.17	2.58	2.30	2.10	2.07	1.97	1.92	1.85	1.90	1.82
Accounts Receivable Turnover	12.97	15.06	9.91	9.83	9.94	13.07	10.44	10.63	10.27	13.00	10.41
Inventory Turnover	7.61	7.44	6.73	6.09	6.03	6.30	6.52	6.81	6.98	7.04	6.39
Fixed Asset Turnover	0.00	0.00	20.45	18.10	16.19	14.53	13.96	13.63	13.09	12.42	11.59
Accounts Payable Turnover	17.68	21.82	16.07	13.56	13.21	16.86	14.59	13.58	12.66	15.01	12.80
Days Sales Outstanding (DSO)	28.14	24.24	36.81	37.15	36.71	27.93	34.96	34.35	35.56	28.08	35.05
Days Inventory Outstanding (DIO)	47.96	49.08	54.24	59.96	60.58	57.91	55.98	53.59	52.28	51.83	57.09
Days Payable Outstanding (DPO)	20.65	16.73	22.72	26.92	27.62	21.65	25.02	26.87	28.82	24.31	28.52
Cash Conversion Cycle (CCC)	55.46	56.59	68.33	70.19	69.67	64.18	65.92	61.07	59.01	55.59	63.63
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	692	584	527	498	455	406	466	455	424	436	482
Invested Capital Turnover	7.21	7.72	6.38	5.61	5.71	6.34	6.17	6.33	6.72	7.01	6.19
Increase / (Decrease) in Invested Capital	115	14	-182	-261	-237	-177	-61	-42	-31	30	17
Enterprise Value (EV)	711	636	532	727	563	765	955	609	660	659	482
Market Capitalization	576	643	616	852	739	993	1,142	806	891	869	635
Book Value per Share	$60.08	$65.30	$67.42	$68.52	$70.14	$72.35	$75.41	$75.31	$76.90	$77.13	$76.69
Tangible Book Value per Share	$53.71	$55.30	$57.57	$58.81	$60.46	$62.52	$65.59	$65.60	$67.14	$67.32	$66.89
Total Capital	921	882	904	916	925	928	947	947	950	942	932
Total Debt	363	292	293	293	293	294	294	294	295	295	295
Total Long-Term Debt	363	292	293	293	293	294	294	294	295	295	295
Net Debt	134	-6.52	-83	-125	-176	-228	-187	-197	-232	-211	-154
Capital Expenditures (CapEx)	12	16	8.97	4.94	4.84	8.42	5.32	6.31	7.36	20	5.93
Debt-free, Cash-free Net Working Capital (DFCFNWC)	656	567	509	474	433	380	442	430	397	395	437
Debt-free Net Working Capital (DFNWC)	885	866	885	893	903	902	924	921	924	900	886
Net Working Capital (NWC)	885	866	885	893	903	902	924	921	924	900	886
Net Nonoperating Expense (NNE)	7.44	8.18	6.09	5.25	4.49	37	3.51	3.61	1.77	3.83	4.45
Net Nonoperating Obligations (NNO)	134	-6.52	-83	-125	-176	-228	-187	-197	-232	-211	-154
Total Depreciation and Amortization (D&A)	6.04	7.01	7.06	7.30	7.44	7.63	8.78	9.47	8.88	8.75	8.90
Debt-free, Cash-free Net Working Capital to Revenue	14.33%	12.75%	12.90%	13.47%	13.25%	12.12%	14.43%	14.25%	13.45%	13.37%	14.88%
Debt-free Net Working Capital to Revenue	19.34%	19.47%	22.44%	25.34%	27.60%	28.75%	30.13%	30.53%	31.26%	30.49%	30.17%
Net Working Capital to Revenue	19.34%	19.47%	22.44%	25.34%	27.60%	28.75%	30.13%	30.53%	31.26%	30.49%	30.17%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$6.44	$3.95	$1.96	$2.70	$2.72	($1.98)	$2.02	$1.65	$1.88	$0.67	$0.33
Adjusted Weighted Average Basic Shares Outstanding	9.04M	9.06M	9.09M	9.00M	8.77M	8.65M	8.66M	8.53M	8.38M	8.29M	8.02M
Adjusted Diluted Earnings per Share	$6.38	$4.46	$1.94	$2.70	$2.71	($1.96)	$2.00	$1.65	$1.87	$0.67	$0.33
Adjusted Weighted Average Diluted Shares Outstanding	9.04M	9.06M	9.09M	9.00M	8.77M	8.65M	8.66M	8.53M	8.38M	8.29M	8.02M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	9.04M	9.06M	9.09M	9.00M	8.77M	8.65M	8.66M	8.53M	8.38M	8.29M	8.02M
Normalized Net Operating Profit after Tax (NOPAT)	67	40	24	30	29	19	21	18	18	9.11	7.26
Normalized NOPAT Margin	6.31%	4.74%	3.00%	3.64%	3.56%	2.67%	2.89%	2.34%	2.38%	1.28%	1.02%
Pre Tax Income Margin	7.60%	4.80%	3.04%	3.94%	4.13%	-1.13%	3.17%	2.48%	2.89%	0.98%	0.58%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	8.72	0.00	4.15	0.00	0.00	0.00	5.98	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	6.41	0.00	3.11	0.00	0.00	0.00	4.54	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	7.56	0.00	2.99	0.00	0.00	0.00	4.83	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	5.25	0.00	1.94	0.00	0.00	0.00	3.39	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	19.66%	22.43%	0.00%	8.67%	29.72%	86.81%	0.00%	118.32%	144.00%	85.28%	156.92%

Financials Breakdown Chart

Key Financial Trends

BlueLinx Holdings Inc. (BXC) — multi-year quarterly trends

Over the last four years, BlueLinx has shown a pattern of revenue volatility with a downshift from the 2022 peak, steady gross margins in the mid-teens, and positive but relatively small net income in most quarters. The company has maintained a solid cash cushion and a modestly leveraged balance sheet, while actively returning capital to shareholders through stock repurchases. Cash flow from operations has been variable, with several quarters posting positive cash flow and a few showing negative cash flow, reflecting working capital dynamics in a cyclical building products market.

Stock repurchases have been a consistent use of cash, with roughly $15 million repurchased in multiple recent quarters (e.g., Q4 2024 and Q1 2025), signaling management’s confidence in value and a focus on per-share results.
Gross margins have remained in the mid-teens across many quarters, indicating stable profitability on BlueLinx’s product mix even as revenue fluctuates.
Net income stayed positive in the latest quarters (for example, Q3 2024 about $16.0 million; Q2 2024 around $14.3 million; Q4 2024 around $5.3 million; Q1 2025 around $2.8 million), suggesting earnings resilience despite topline volatility.
The balance sheet shows a manageable debt load, with long-term debt near $294–295 million and total liabilities under $1 billion, supporting a reasonable leverage profile.
The company maintains a robust cash position, with cash and equivalents typically in the $450–526 million range in the more recent periods, providing liquidity to weather cyclical swings.
Revenue has trended lower versus the 2022 peak, with latest quarters in the ~$700 million range, indicating a slower top-line growth trajectory.
Operating cash flow has been uneven, turning positive in several quarters but negative in others (e.g., negative in Q1 2025 and Q1 2024), reflecting working capital effects and cyclical demand.
Revenue softness and earnings variability contribute to relatively thin net income margins, which may pose a challenge if demand weakens further.
Certain quarters show negative cash flow from operating activities, highlighting near-term liquidity pressure from working capital changes during down or flat cycles.
Ongoing capital returns via buybacks, while favorable to per-share metrics, reduce cash reserves that could be needed during sharper industry downturns or margin compression.

05/05/26 03:32 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About BlueLinx's Financials

When does BlueLinx's fiscal year end?

According to the most recent income statement we have on file, BlueLinx's financial year ends in December. Their financial year 2024 ended on December 28, 2024.

How has BlueLinx's net income changed over the last 2 years?

BlueLinx's net income appears to be on a downward trend, with a most recent value of $53.12 million in 2024, falling from $296.18 million in 2022. The previous period was $48.54 million in 2023. Find out what analysts predict for BlueLinx in the coming months.

What is BlueLinx's operating income?

BlueLinx's total operating income in 2024 was $87.57 million, based on the following breakdown:

Total Gross Profit: $489.14 million
Total Operating Expenses: $401.57 million

How has BlueLinx's revenue changed over the last 2 years?

Over the last 2 years, BlueLinx's total revenue changed from $4.45 billion in 2022 to $2.95 billion in 2024, a change of -33.7%.

How much debt does BlueLinx have?

BlueLinx's total liabilities were at $931.28 million at the end of 2024, a 3.1% increase from 2023, and a 3.5% increase since 2022.

How much cash does BlueLinx have?

In the past 2 years, BlueLinx's cash and equivalents has ranged from $298.94 million in 2022 to $521.74 million in 2023, and is currently $505.62 million as of their latest financial filing in 2024.

How has BlueLinx's book value per share changed over the last 2 years?

Over the last 2 years, BlueLinx's book value per share changed from 65.30 in 2022 to 77.13 in 2024, a change of 18.1%.

Related Companies

Financial statements for NYSE:BXC last updated on 4/30/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BlueLinx (BXC) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About BlueLinx's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

BlueLinx (BXC) Financials

Annual Income Statements for BlueLinx

Quarterly Income Statements for BlueLinx

Annual Cash Flow Statements for BlueLinx

Quarterly Cash Flow Statements for BlueLinx

Annual Balance Sheets for BlueLinx

Quarterly Balance Sheets for BlueLinx

Annual Metrics And Ratios for BlueLinx

Quarterly Metrics And Ratios for BlueLinx

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About BlueLinx's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools